Advances in antiretroviral therapy.

  title={Advances in antiretroviral therapy.},
  author={J. S. P. Jones and Barbara Taylor and Timothy J. Wilkin and Scott M. Hammer},
  journal={Topics in HIV medicine : a publication of the International AIDS Society, USA},
  volume={18 2},
The 14th Conference on Retroviruses and Opportunistic Infections provided a forum for presentation of state-of-the-art research on antiretroviral therapy. This year's conference marked the first public presentation of phase III trials of the lead compounds in 2 new drug classes: maraviroc (a CCR5 inhibitor) and raltegravir (an HIV-1 integrase inhibitor). These agents are likely to be approved by the US Food and Drug Administration this year and should provide major new options for treatment… CONTINUE READING